CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

CCTA-based approach

4 min read

Cleerly Value to Health Systems: Precision Heart Care Reduces Risk and Improves Patient Care

Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to unnecessary and expensive invasive procedures.

Cleerly’s coronary computed tomography angiography...

Read More »

2 min read

Cleerly Value to Health Plans: Precision Heart Care Reduces Waste and Improves Patient Experience

Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into provider workflows and patient care journeys.

Our personalized care pathway for heart attack prevention...

Read More »

3 min read

Cleerly Value to Private Practice: Precision Heart Care Allows for Personalized Heart Disease Evaluation

Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease is suspected or identified by these methods, patients must often be referred to a specialist for...

Read More »

2 min read

What to Expect with a CCTA Scan

Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA) imaging that guides physicians towards creating personalized and preventive treatment plans for patients. To...

Read More »

3 min read

Transforming Cardiac Care: A New Cleerly Webinar Series

There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.

Read More »

1 min read

Cleerly CEO Featured on AWS Health Innovation Podcast

Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.

Read More »

3 min read

CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods

Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease evaluation.

Read More »

2 min read

Cleerly Product Release:  Taking Precision Heart Care to the Next Level

As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to drive new efficiencies and deliver new insights to our customers.

Read More »